Literature DB >> 29224040

Treatment of auditory hallucinations with bilateral theta burst stimulation (cTBS): protocol of a randomized, double-blind, placebo-controlled, multicenter trial.

Christian Plewnia1, Bettina Brendel2,3, Tobias Schwippel2, Peter Martus3, Joachim Cordes4, Alkomiet Hasan5, Andreas J Fallgatter2.   

Abstract

Auditory verbal hallucinations (AH) are core symptoms of schizophrenia. They are often severely distressing and refractory to therapy. Their perception is associated with increased activity in temporoparietal areas of the brain. Repetitive transcranial magnetic stimulation (rTMS) can reduce focal brain hyperactivity and has been shown to ameliorate AH. However, controlled multicenter clinical trials are still missing, effect sizes are moderate, and the treatment with rTMS is time consuming. Continuous theta burst stimulation (cTBS) is a quicker and potentially more effective technique to reduce cortical hyperactivity. First case and pilot studies indicate effectiveness in the treatment of AH. In this randomized, sham-controlled, double-blind multicenter clinical trial, 86 patients with schizophrenia spectrum disorder will be randomized to either cTBS or sham to the left and right temporoparietal cortex during three consecutive weeks (15 sessions totally). In each session, both hemispheres will be stimulated sequentially. The order in the first session (left-right or right-left, respectively) will be determined by randomization and alternated in all following sessions. Primary outcome is the reduction of mean PSYRATS-AH score after cTBS as compared to sham treatment. Follow-up measurements will be performed 1, 3 and 6 months after the end of the treatment. Statistical analysis will be based on the intention-to-treat population including all randomized patients using an analysis of covariance. This multicenter-controlled clinical trial will be able to provide decisive evidence for the efficacy of cTBS in the treatment of AH. The results will be suitable to clarify the role of this innovative, pathophysiology-based therapeutic approach in treatment guidelines for AH. TRIAL REGISTRY: ClinicalTrials.gov identifier: NCT02670291.

Entities:  

Keywords:  Auditory hallucinations; Brain stimulation; Clinical study; Schizophrenia; Therapy; Transcranial magnetic stimulation

Mesh:

Substances:

Year:  2017        PMID: 29224040     DOI: 10.1007/s00406-017-0861-3

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  55 in total

1.  Disinhibition of the contralateral motor cortex by low-frequency rTMS.

Authors:  Christian Plewnia; Martin Lotze; Christian Gerloff
Journal:  Neuroreport       Date:  2003-03-24       Impact factor: 1.837

Review 2.  Neuroimaging auditory hallucinations in schizophrenia: from neuroanatomy to neurochemistry and beyond.

Authors:  Paul Allen; Gemma Modinos; Daniela Hubl; Gregory Shields; Arnaud Cachia; Renaud Jardri; Pierre Thomas; Todd Woodward; Paul Shotbolt; Marion Plaze; Ralph Hoffman
Journal:  Schizophr Bull       Date:  2012-04-25       Impact factor: 9.306

3.  The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation.

Authors:  S R Kay; L A Opler; J P Lindenmayer
Journal:  Br J Psychiatry Suppl       Date:  1989-11

Review 4.  Repetitive transcranial magnetic stimulation in the treatment of auditory hallucinations in schizophrenic patients.

Authors:  Aurélie Montagne-Larmurier; Olivier Etard; Olivier Maïza; Sonia Dollfus
Journal:  Curr Opin Psychiatry       Date:  2011-11       Impact factor: 4.741

5.  Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application.

Authors:  Stefan Leucht
Journal:  J Clin Psychiatry       Date:  2014       Impact factor: 4.384

6.  Bilateral prefrontal rTMS and theta burst TMS as an add-on treatment for depression: a randomized placebo controlled trial.

Authors:  Julia Prasser; Martin Schecklmann; Timm B Poeppl; Elmar Frank; Peter M Kreuzer; Goeran Hajak; Rainer Rupprecht; Michael Landgrebe; Berthold Langguth
Journal:  World J Biol Psychiatry       Date:  2014-11-28       Impact factor: 4.132

7.  Transcranial magnetic stimulation of Wernicke's and Right homologous sites to curtail "voices": a randomized trial.

Authors:  Ralph E Hoffman; Kun Wu; Brian Pittman; John D Cahill; Keith A Hawkins; Thomas Fernandez; Jonas Hannestad
Journal:  Biol Psychiatry       Date:  2013-02-26       Impact factor: 13.382

8.  Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations.

Authors:  Stephen M Lawrie; Christian Buechel; Heather C Whalley; Christopher D Frith; Karl J Friston; Eve C Johnstone
Journal:  Biol Psychiatry       Date:  2002-06-15       Impact factor: 13.382

9.  Cerebral blood flow identifies responders to transcranial magnetic stimulation in auditory verbal hallucinations.

Authors:  P Homan; J Kindler; M Hauf; D Hubl; T Dierks
Journal:  Transl Psychiatry       Date:  2012-11-20       Impact factor: 6.222

10.  Short and long term effects of left and bilateral repetitive transcranial magnetic stimulation in schizophrenia patients with auditory verbal hallucinations: a randomized controlled trial.

Authors:  Leonie Bais; Ans Vercammen; Roy Stewart; Frank van Es; Bert Visser; André Aleman; Henderikus Knegtering
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

View more
  1 in total

1.  COMT-Val158Met polymorphism modulates antipsychotic effects on auditory verbal hallucinations and temporal lobe gray matter volumes in healthy individuals-symptom relief accompanied by worrisome volume reductions.

Authors:  Chuanjun Zhuo; Langlang Cheng; Gongying Li; Yong Xu; Rixing Jing; Shen Li; Li Zhang; Xiaodong Lin; Chunhua Zhou
Journal:  Brain Imaging Behav       Date:  2020-10       Impact factor: 3.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.